Recommendation based on a Phase 3 trial showing a significantly greater proportion of children on Dupixent achieved histological remission ...

The newest variant of COVID-19 has yet to enter the state, but allergy symptoms could have you feeling like they have. How to ...

AstraZeneca’s FASENRA® (benralizumab) has been approved in the US for the treatment of adult patients with eosinophilic granulomatosis with polyangiitis (EGPA).1 EGPA is a rare, immune-mediated ...

The FDA broadened dupilumab's (Dupixent) approval as an add-on maintenance treatment for chronic rhinosinusitis with nasal ...

US wastewater samples are showing an alarming increase in a respiratory virus that has been linked to polio-like symptoms. An enterovirus variant ... via respiratory secretions like saliva or nasal ...

Approximately 9,000 adolescents in the US are living with inadequately controlled cases of the chronic disease ...

Sen. JD Vance (R-Ohio), the Republican vice presidential candidate, is backtracking on whether President Trump would veto a ...

Following Priority Review, Dupixent is now available to patients as young as 12 years with inadequately controlled CRSwNPCurrent treatment ...

In a recent study investigators established that extended dupilumab therapy-up to three years-is highly effective in the ...

For technical reasons, the English full text will be published approximately two weeks after the German print edition has been published.

The effects of the epilepsy drug need further investigation, but it appears to have had positive results on snoring.

When you should seek treatment for snoring – amid new drug hopes - Loud disruptive snoring could be a symptom of something ...